Guardant Hereditary Cancer Test - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

A heavy-lift vessel installs an offshore converter platform as Larsen & Toubro expands its European renewable-energy infrastructure pipeline through the ultra-mega TenneT offshore wind framework. Representative image.

Did Larsen & Toubro really win Rs 55,000Cr order? Official TenneT filing points to a different figure

A smart-glasses engineering workspace reflects Magic Leap’s 269 planned job cuts as the augmented reality pioneer exits first-party devices and pivots towards supplying waveguides and optical technology for artificial intelligence glasses. Representative image.

Magic Leap layoffs rise to 269 as augmented reality pioneer abandons first-party devices

Representative image showing large-scale iron ore mining operations, reflecting investor focus on Rio Tinto plc’s capital intensity, iron ore margins, and balance-sheet pressures following its 2025 results and share price decline.

Fortescue (ASX: FMG) shares fall as $525m Iron Bridge impairment overshadows record shipments

CBIZ to be taken private by Grant Thornton in largest US accounting M&A in 25+ years

Guardant Health launches Hereditary Cancer Test to expand precision oncology offerings

Read More

Healthcare Industry News

Guardant Health launches Hereditary Cancer Test to expand precision oncology offerings

Guardant Health unveils its new hereditary cancer test to detect inherited genetic risks across 12+ cancer types. Learn how this aids precision treatment plans.

byPallavi Madhiraju

May 20, 2025

web analytics